Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 1125

1.

Tumor-Associated Macrophages: Therapeutic Targets for Skin Cancer.

Fujimura T, Kambayashi Y, Fujisawa Y, Hidaka T, Aiba S.

Front Oncol. 2018 Jan 23;8:3. doi: 10.3389/fonc.2018.00003. eCollection 2018. Review.

2.

Baseline neutrophil to lymphocyte ratio combined with serum LDH level associated with outcome of nivolumab immunotherapy in a Japanese advanced melanoma population.

Fujisawa Y, Yoshino K, Otsuka A, Funakoshi T, Fujimura T, Yamamoto Y, Hata H, Tanaka R, Yamaguchi K, Nonomura Y, Hirai I, Furudate S, Okuhira H, Imafuku K, Aoki M, Matsushita S.

Br J Dermatol. 2018 Feb 6. doi: 10.1111/bjd.16427. [Epub ahead of print]

PMID:
29405254
3.

Characteristics of hepatic insulin-sensitive nonalcoholic fatty liver disease.

Shigiyama F, Kumashiro N, Furukawa Y, Funayama T, Takeno K, Wakui N, Ikehara T, Nagai H, Taka H, Fujimura T, Uchino H, Tamura Y, Watada H, Nemoto T, Shiraga N, Sumino Y, Hirose T.

Hepatol Commun. 2017 Jul 29;1(7):634-647. doi: 10.1002/hep4.1077. eCollection 2017 Sep.

4.

Association of Impact Velocity with Serious-injury and Fatality Risks to Cyclists in Commercial Truck-Cyclist Accidents.

Matsui Y, Oikawa S, Sorimachi K, Imanishi A, Fujimura T.

Stapp Car Crash J. 2017 Nov;61:355-371.

PMID:
29394445
5.

TRIM25 enhances cell growth and cell survival by modulating p53 signals via interaction with G3BP2 in prostate cancer.

Takayama KI, Suzuki T, Tanaka T, Fujimura T, Takahashi S, Urano T, Ikeda K, Inoue S.

Oncogene. 2018 Jan 30. doi: 10.1038/s41388-017-0095-x. [Epub ahead of print]

PMID:
29379164
6.

Association of USP10 with G3BP2 Inhibits p53 Signaling and Contributes to Poor Outcome in Prostate Cancer.

Takayama KI, Suzuki T, Fujimura T, Takahashi S, Inoue S.

Mol Cancer Res. 2018 Jan 29. pii: molcanres.0471.2017. doi: 10.1158/1541-7786.MCR-17-0471. [Epub ahead of print]

PMID:
29378906
7.

Estrogen and Androgen Blockade for Advanced Prostate Cancer in the Era of Precision Medicine.

Fujimura T, Takayama K, Takahashi S, Inoue S.

Cancers (Basel). 2018 Jan 23;10(2). pii: E29. doi: 10.3390/cancers10020029. Review.

8.

Development and validation of a facial expression database based on the dimensional and categorical model of emotions.

Fujimura T, Umemura H.

Cogn Emot. 2018 Jan 15:1-8. doi: 10.1080/02699931.2017.1419936. [Epub ahead of print]

PMID:
29334821
9.

Extent of Hunner lesions: The relationships with symptom severity and clinical parameters in Hunner type interstitial cystitis patients.

Akiyama Y, Niimi A, Nomiya A, Yamada Y, Nakagawa T, Fujimura T, Fukuhara H, Kume H, Igawa Y, Homma Y.

Neurourol Urodyn. 2018 Jan 9. doi: 10.1002/nau.23467. [Epub ahead of print]

PMID:
29315774
10.

Purine salvage in plants.

Ashihara H, Stasolla C, Fujimura T, Crozier A.

Phytochemistry. 2018 Mar;147:89-124. doi: 10.1016/j.phytochem.2017.12.008. Epub 2018 Jan 4. Review.

PMID:
29306799
11.

The Expression of Matrix Metalloproteinases in Receptor Activator of Nuclear Factor Kappa-B Ligand (RANKL)-expressing Cancer of Apocrine Origin.

Kambayashi Y, Fujimura T, Furudate S, Lyu C, Hidaka T, Kakizaki A, Sato Y, Tanita K, Aiba S.

Anticancer Res. 2018 Jan;38(1):113-120.

PMID:
29277763
12.

Mechanisms of carnosine-induced activation of neuronal cells.

Yamashita S, Sato M, Matsumoto T, Kadooka K, Hasegawa T, Fujimura T, Katakura Y.

Biosci Biotechnol Biochem. 2017 Dec 11:1-6. doi: 10.1080/09168451.2017.1413325. [Epub ahead of print]

PMID:
29224504
13.

Design, Synthesis and Cytotoxicity Evaluation of New 3, 5-Disubstituted-2-Thioxoimidazolidinones.

Abdellatif K, Elbadawi MM, Elsaady MT, El-Hafeez AAA, Fujimura T, Kawamoto S, Khodair AI.

Anticancer Agents Med Chem. 2017 Nov 29. doi: 10.2174/1871520618666171129213838. [Epub ahead of print]

PMID:
29189182
14.

Preoperative chronic kidney disease is predictive of oncological outcome of radical cystectomy for bladder cancer.

Matsumoto A, Nakagawa T, Kanatani A, Ikeda M, Kawai T, Miyakawa J, Taguchi S, Naito A, Otsuka M, Nakanishi Y, Suzuki M, Koga F, Nagase Y, Kondo Y, Okaneya T, Tanaka Y, Miyazaki H, Fujimura T, Fukuhara H, Kume H, Igawa Y, Homma Y.

World J Urol. 2018 Feb;36(2):249-256. doi: 10.1007/s00345-017-2141-2. Epub 2017 Nov 28.

PMID:
29185045
15.

Increased serum production of soluble CD163 and CXCL5 in patients with moyamoya disease: Involvement of intrinsic immune reaction in its pathogenesis.

Fujimura M, Fujimura T, Kakizaki A, Sato-Maeda M, Niizuma K, Tomata Y, Aiba S, Tominaga T.

Brain Res. 2018 Jan 15;1679:39-44. doi: 10.1016/j.brainres.2017.11.013. Epub 2017 Nov 22.

PMID:
29174692
16.

Ethnic differences in stratum corneum functions between Chinese and Thai infants residing in Bangkok, Thailand.

Fujimura T, Miyauchi Y, Shima K, Hotta M, Tsujimura H, Kitahara T, Takema Y, Palungwachira P, Laohathai D, Chanthothai J, Nararatwanchai T.

Pediatr Dermatol. 2018 Jan;35(1):87-91. doi: 10.1111/pde.13335. Epub 2017 Nov 15.

PMID:
29143471
17.

Impact of guidewire recrossing point into stent jailed side branch for optimal kissing balloon dilatation: core lab 3D optical coherence tomography analysis.

Okamura T, Nagoshi R, Fujimura T, Murasato Y, Yamawaki M, Ono S, Serikawa T, Hikichi Y, Norita H, Nakao F, Sakamoto T, Shinke T, Shite J.

EuroIntervention. 2018 Feb 2;13(15):e1785-e1793. doi: 10.4244/EIJ-D-17-00591.

18.

Properties of Skin in Chinese Infants: Developmental Changes in Ceramides and in Protein Secondary Structure of the Stratum Corneum.

Yuan C, Zou Y, Xueqiu Y, Shima K, Miyauchi Y, Naoe A, Naito S, Fujimura T, Hotta M, Kitahara T, Wang X.

Biomed Res Int. 2017;2017:3594629. doi: 10.1155/2017/3594629. Epub 2017 Oct 2.

19.

Retrospective study of advanced melanoma patients treated with ipilimumab after nivolumab: Analysis of 60 Japanese patients.

Fujisawa Y, Yoshino K, Otsuka A, Funakoshi T, Uchi H, Fujimura T, Matsushita S, Hata H, Okuhira H, Tanaka R, Nagai K, Ishida Y, Nakamura Y, Furudate S, Yamamura K, Imafuku K, Yamamoto Y.

J Dermatol Sci. 2018 Jan;89(1):60-66. doi: 10.1016/j.jdermsci.2017.10.009. Epub 2017 Oct 25.

PMID:
29079332
20.

Serial changes in the side-branch ostial area after main-vessel stenting with kissing balloon inflation for coronary bifurcation lesions, assessed by 3D optical coherence tomography.

Fujimura T, Okamura T, Tateishi H, Nakamura T, Yamada J, Oda T, Mochizuki M, Nishimura S, Nishimura T, Yano M.

Eur Heart J Cardiovasc Imaging. 2017 Oct 23. doi: 10.1093/ehjci/jex213. [Epub ahead of print]

PMID:
29069325
21.

Successful treatment of relapsed folliculotropic mycosis fungoides with mogamulizumab followed by intensity-modulated radiotherapy.

Fujimura T, Furudate S, Tanita K, Sato Y, Kambayashi Y, Hidaka T, Aiba S.

J Dermatol. 2017 Oct 25. doi: 10.1111/1346-8138.14111. [Epub ahead of print] No abstract available.

PMID:
29068082
22.
23.

Phase I study of nivolumab combined with IFN-β for patients with advanced melanoma.

Fujimura T, Hidaka T, Kambayashi Y, Furudate S, Kakizaki A, Tono H, Tsukada A, Haga T, Hashimoto A, Morimoto R, Yamaguchi T, Takano T, Aiba S.

Oncotarget. 2017 Apr 13;8(41):71181-71187. doi: 10.18632/oncotarget.17090. eCollection 2017 Sep 19.

24.

Diagnostic value of urinary CXCL10 as a biomarker for predicting Hunner type interstitial cystitis.

Niimi A, Igawa Y, Aizawa N, Honma T, Nomiya A, Akiyama Y, Kamei J, Fujimura T, Fukuhara H, Homma Y.

Neurourol Urodyn. 2017 Oct 19. doi: 10.1002/nau.23431. [Epub ahead of print]

PMID:
29048741
25.

Feasibility and usefulness of three-dimensional optical coherence tomography guidance for optimal side branch treatment in coronary bifurcation stenting.

Nagoshi R, Okamura T, Murasato Y, Fujimura T, Yamawaki M, Ono S, Serikawa T, Hikichi Y, Nakao F, Sakamoto T, Shinke T, Kijima Y, Kozuki A, Shibata H, Shite J.

Int J Cardiol. 2018 Jan 1;250:270-274. doi: 10.1016/j.ijcard.2017.09.197. Epub 2017 Oct 5.

PMID:
29030141
26.

Prominent IgE-binding and cytokine-inducing capacities of a newly cloned N-terminal region of Der f 14, an apolipophorin-like house dust mite allergen.

ElRamlawy KG, Fujimura T, Aki T, Okada A, Suzuki T, Abe T, Hayashi T, Epton MJ, Thomas WR, Rafeet IH, Al-Azhary DB, Ono K, Kawamoto S.

J Biochem. 2018 Jan 1;163(1):51-60. doi: 10.1093/jb/mvx060.

PMID:
28992042
27.

Severe erythema exudative multiforme developing from advanced melanoma treated with dabrafenib and trametinib followed by nivolumab.

Fujimura T, Kambayashi Y, Hidaka T, Tamabuchi E, Otake E, Tono H, Mizuashi M, Furudate S, Aiba S.

J Dermatol. 2018 Feb;45(2):e35-e36. doi: 10.1111/1346-8138.14085. Epub 2017 Oct 6. No abstract available.

PMID:
28983948
28.

Successful control of phototherapy-resistant lymphomatoid papulosis with oral bexarotene.

Fujimura T, Furudate S, Tanita K, Sato Y, Kambayashi Y, Hidaka T, Aiba S.

J Dermatol. 2018 Feb;45(2):e37-e38. doi: 10.1111/1346-8138.14095. Epub 2017 Oct 3. No abstract available.

PMID:
28971510
29.

Biochemical and immunological characterization of a novel monoclonal antibody against mouse leukotriene B4 receptor 1.

Sasaki F, Koga T, Saeki K, Okuno T, Kazuno S, Fujimura T, Ohkawa Y, Yokomizo T.

PLoS One. 2017 Sep 18;12(9):e0185133. doi: 10.1371/journal.pone.0185133. eCollection 2017.

30.

Dysregulation of spliceosome gene expression in advanced prostate cancer by RNA-binding protein PSF.

Takayama KI, Suzuki T, Fujimura T, Yamada Y, Takahashi S, Homma Y, Suzuki Y, Inoue S.

Proc Natl Acad Sci U S A. 2017 Sep 26;114(39):10461-10466. doi: 10.1073/pnas.1706076114. Epub 2017 Sep 11.

PMID:
28893982
31.

Plasma Cluster Ions Reduce the IgE-Binding Capacity of House Dust Mite Allergens under a Simulated Indoor Environmental Condition.

Okano H, Fujimura T, Fukuoka N, Hayashi T, Nishikawa K, Ono K, Kawamoto S.

Int Arch Allergy Immunol. 2017;173(4):199-203. doi: 10.1159/000477724. Epub 2017 Aug 29.

PMID:
28848159
32.

Cytotoxic antimelanoma drugs suppress the activation of M2 macrophages.

Fujimura T, Kakizaki A, Kambayashi Y, Sato Y, Tanita K, Lyu C, Furudate S, Aiba S.

Exp Dermatol. 2018 Jan;27(1):64-70. doi: 10.1111/exd.13417. Epub 2017 Oct 26.

PMID:
28833504
33.

Characteristics of the mechanosensitive bladder afferent activities in relation with microcontractions in male rats with bladder outlet obstruction.

Aizawa N, Ichihara K, Fukuhara H, Fujimura T, Andersson KE, Homma Y, Igawa Y.

Sci Rep. 2017 Aug 9;7(1):7646. doi: 10.1038/s41598-017-07898-y.

34.

Synergistic tumor suppression by a Perilla frutescens-derived methoxyflavanone and anti-cancer tyrosine kinase inhibitors in A549 human lung adenocarcinoma.

Abd El-Hafeez AA, Fujimura T, Kamei R, Hirakawa N, Baba K, Ono K, Kawamoto S.

Cytotechnology. 2017 Jul 29. doi: 10.1007/s10616-017-0124-1. [Epub ahead of print]

PMID:
28756527
35.

A novel moonlight function of glyceraldehyde-3-phosphate dehydrogenase (GAPDH) for immunomodulation.

Nakano T, Goto S, Takaoka Y, Tseng HP, Fujimura T, Kawamoto S, Ono K, Chen CL.

Biofactors. 2017 Jul 28. doi: 10.1002/biof.1379. [Epub ahead of print]

PMID:
28753256
36.

Fluctuations in routine blood count might signal severe immune-related adverse events in melanoma patients treated with nivolumab.

Fujisawa Y, Yoshino K, Otsuka A, Funakoshi T, Fujimura T, Yamamoto Y, Hata H, Gosho M, Tanaka R, Yamaguchi K, Nonomura Y, Hirai I, Furudate S, Okuhira H, Imafuku K, Aoki M, Matsushita S.

J Dermatol Sci. 2017 Nov;88(2):225-231. doi: 10.1016/j.jdermsci.2017.07.007. Epub 2017 Jul 16.

PMID:
28736218
37.

A methoxyflavanone derivative from the Asian medicinal herb (Perilla frutescens) induces p53-mediated G2/M cell cycle arrest and apoptosis in A549 human lung adenocarcinoma.

Abd El-Hafeez AA, Fujimura T, Kamei R, Hirakawa N, Baba K, Ono K, Kawamoto S.

Cytotechnology. 2017 Jul 14. doi: 10.1007/s10616-017-0116-1. [Epub ahead of print]

PMID:
28710570
38.

Predictors of Early Continence after Robot-assisted Radical Prostatectomy.

Yamada Y, Fujimura T, Fukuhara H, Sugihara T, Nakagawa T, Kume H, Igawa Y, Homma Y.

Low Urin Tract Symptoms. 2017 Jul 11. doi: 10.1111/luts.12181. [Epub ahead of print]

PMID:
28699263
39.

Overactive bladder is a negative predictor of achieving continence after robot-assisted radical prostatectomy.

Yamada Y, Fujimura T, Fukuhara H, Sugihara T, Miyazaki H, Nakagawa T, Kume H, Igawa Y, Homma Y.

Int J Urol. 2017 Oct;24(10):749-756. doi: 10.1111/iju.13411. Epub 2017 Jul 11.

PMID:
28697538
40.

Androgen induces G3BP2 and SUMO-mediated p53 nuclear export in prostate cancer.

Ashikari D, Takayama K, Tanaka T, Suzuki Y, Obinata D, Fujimura T, Urano T, Takahashi S, Inoue S.

Oncogene. 2017 Nov 9;36(45):6272-6281. doi: 10.1038/onc.2017.225. Epub 2017 Jul 10.

PMID:
28692047
41.

Oncologic Outcome of Metastasectomy for Urothelial Carcinoma: Who Is the Best Candidate?

Nakagawa T, Taguchi S, Kanatani A, Kawai T, Ikeda M, Urakami S, Matsumoto A, Komemushi Y, Miyakawa J, Yamada D, Suzuki M, Enomoto Y, Nishimatsu H, Kondo Y, Nagase Y, Hirano Y, Okaneya T, Tanaka Y, Miyazaki H, Fujimura T, Fukuhara H, Kume H, Igawa Y, Homma Y.

Ann Surg Oncol. 2017 Sep;24(9):2794-2800. doi: 10.1245/s10434-017-5970-8. Epub 2017 Jul 7.

PMID:
28687875
42.

Immunomodulatory Effect of Imiquimod Through CCL22 Produced by Tumor-associated Macrophages in B16F10 Melanomas.

Furudate S, Fujimura T, Kambayashi Y, Kakizaki A, Hidaka T, Aiba S.

Anticancer Res. 2017 Jul;37(7):3461-3471.

PMID:
28668835
43.

Robot-assisted radical prostatectomy significantly reduced biochemical recurrence compared to retro pubic radical prostatectomy.

Fujimura T, Fukuhara H, Taguchi S, Yamada Y, Sugihara T, Nakagawa T, Niimi A, Kume H, Igawa Y, Homma Y.

BMC Cancer. 2017 Jun 29;17(1):454. doi: 10.1186/s12885-017-3439-6.

44.

Very Late Strut Overhang on Coronary Angioscopy After Bioresorbable Vascular Scaffold Implantation in a Clinically Stable Patient.

Fujimura T, Kawasaki T, Kimura T.

Circ J. 2017 Jun 27. doi: 10.1253/circj.CJ-17-0383. [Epub ahead of print] No abstract available.

45.

Sarcoidosis-Lymphoma Syndrome Associated with Folliculotropic Peripheral T Cell Lymphoma Not Otherwise Specified.

Yoshida S, Fujimura T, Kambayashi Y, Furudate S, Mizuashi M, Aiba S.

Case Rep Oncol. 2017 Apr 24;10(1):372-376. doi: 10.1159/000472249. eCollection 2017 Jan-Apr.

46.

The Immunological Roles of Periostin/Tumor-Associated Macrophage Axis in Development of Dermatofibrosarcoma Protuberans.

Fujimura T, Kakizaki A, Sato Y, Tanita K, Furudate S, Aiba S.

Anticancer Res. 2017 Jun;37(6):2867-2873.

PMID:
28551623
47.

Evaluation of the effects of gastrectomy on the development of metabolic bone disease.

Higashi Y, Fujimura T, Oyama K, Kinoshita J, Miyashita T, Tajima H, Fushida S, Ohta T.

J Surg Res. 2017 May 15;212:1-7. doi: 10.1016/j.jss.2016.11.057. Epub 2016 Dec 12.

PMID:
28550894
48.

Successful Treatment of Primary Cutaneous Peripheral T-Cell Lymphoma Presenting Acquired Ichthyosis with Oral Bexarotene Monotherapy.

Tanita K, Fujimura T, Sato Y, Hidaka T, Furudate S, Kambayashi Y, Tsukada A, Hashimoto A, Aiba S.

Case Rep Oncol. 2017 Apr 6;10(1):328-332. doi: 10.1159/000468981. eCollection 2017 Jan-Apr.

49.

Phospho-STAT5B Expression Is a Prognostic Marker for Merkel Cell Carcinoma.

Fujimura T, Furudate S, Kambayahsi Y, Kakizaki A, Yamamoto Y, Okuhira H, Fujimoto N, Aiba S.

Anticancer Res. 2017 May;37(5):2335-2341.

PMID:
28476799
50.

Keratoacanthoma, palmoplantar keratoderma developing in an advanced melanoma patient treated with vemurafenib regressed by blockade of mitogen-activated protein kinase kinase signaling.

Furudate S, Fujimura T, Kambayashi Y, Hidaka T, Sato Y, Tanita K, Hashimoto A, Aiba S.

J Dermatol. 2017 Sep;44(9):e226-e227. doi: 10.1111/1346-8138.13898. Epub 2017 Apr 25. No abstract available.

PMID:
28439948

Supplemental Content

Loading ...
Support Center